CLINICAL_TRIALS
trial_result
· 2024-03-20
Clinical Trial Update: Azelastine Allergen Chamber - Onset of Action Study [Phase 2]
Summary
Phase 2 clinical trial updating on onset of action for azelastine in an allergen chamber for seasonal allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED